Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Shehab AlAnsari"'
Publikováno v:
Diagnostics, Vol 5, Iss 2, Pp 254-271 (2015)
Adrenal vein sampling (AVS) is the gold standard test to determine unilateral causes of primary aldosteronism (PA). We have retrospectively characterized our experience with AVS including concordance of AVS results and imaging, and describe the appro
Externí odkaz:
https://doaj.org/article/9a8f6b38fc804ebe88bb09077a4e2663
Autor:
Ali Fuad, W.H. Wilson Tang, Brian D. Southern, Allen G. Borowski, Haris Riaz, Vikram Sharma, Omar Alawadhi, Shehab AlAnsari, Nauman Khan
Publikováno v:
Journal of Interdisciplinary Medicine, Vol 5, Iss 2, Pp 35-42 (2020)
Aim: Pirfenidone is a novel anti-fibrotic agent utilized in the treatment of idiopathic pulmonary fibrosis (IPF). It has been implicated in mitigating myocardial fibrosis and left ventricular (LV) systolic and diastolic dysfunction in animal models.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e067dfd1a6c4d5dc36d10c5731d178c
https://doaj.org/article/28d63bae679f4d4498faf32863887b5f
https://doaj.org/article/28d63bae679f4d4498faf32863887b5f
Autor:
Mohan L Maradumane, Vikram Sharma, Ruchi Sharma, Sathyamangala Prasad, Conner P Witherow, Venu Menon, Wai Hong W Tang, Shehab AlAnsari
Publikováno v:
Circulation. 142
Introduction: Circulating blood troponin complexes and free fractions remain poorly characterised in different conditions where troponin is detectable in blood Hypothesis: The aim of the study was to compare the differences in troponin-I(TnI) complex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7a0b3ab4abd1796f59870dc1886bce7
https://doi.org/10.1161/circ.142.suppl_3.16716
https://doi.org/10.1161/circ.142.suppl_3.16716
Autor:
Douglas R. Johnston, M.Z. Tong, Eric E. Roselli, Kevin Chen, Eugene H. Blackstone, Faisal G. Bakaeen, A. Marc Gillinov, Shehab AlAnsari, Samir R. Kapadia, Gösta B. Pettersson, Beni R Verma, Edward G. Soltesz, Per Wierup, Lars G. Svensson, Stephen G. Ellis, Conrad Simpfendorfer, Vikram Sharma
Publikováno v:
The Annals of thoracic surgery. 111(5)
Background Early coronary ischemic events are uncommon after cardiac surgery, with little known about their management or associated outcomes. We evaluated clinical outcomes of patients undergoing coronary angiography ± percutaneous coronary interve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f739f6910325b1a45b785e5ae539dc
https://pubmed.ncbi.nlm.nih.gov/32946843
https://pubmed.ncbi.nlm.nih.gov/32946843
Autor:
WaiYan Soe, Gauranga Mahalwar, Allan L. Klein, W.H. Wilson Tang, David F. Warner, Muhammad Furqan, Michael Tong, Shehab AlAnsari
Publikováno v:
Journal of Cardiac Failure. 26:S148-S149
Background Extracorporeal membrane oxygenation(ECMO) for the treatment of refractory cardiogenic shock has gained popularity over the last decade. Cardiac tamponade(CT), a life threatening condition, has been reported to occur in patients after the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03036a272c8924f071b1ff6fb35eeb9b
https://doi.org/10.1016/j.cardfail.2020.09.428
https://doi.org/10.1016/j.cardfail.2020.09.428
Autor:
Tanujit Dey, Samir R. Kapadia, Amar Krishnaswamy, Shehab AlAnsari, Kesavan Sankaramangalam, Lars G. Svensson, Vikram Sharma, Stephanie Mick, Louis Williams
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Troponin elevation occurs commonly in the setting of transcatheter aortic valve replacement (TAVR). There is a lack of information on the extent of troponin elevation post TAVR that is prognostically significant. We assessed the optimal cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9378e470110ccb53f7decdbc87944794
http://europepmc.org/articles/PMC6662140
http://europepmc.org/articles/PMC6662140
Publikováno v:
Journal of Cardiac Failure. 26:S25
Background To date, there remains to be a lack of effective treatment modalities for HFpEF, which accounts for approximately 50% of all cases of congestive heart failure. Pirfenidone is a novel anti-fibrotic agent that has been shown to improve pulmo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75e10f983ddf1fd7b8e054cb9cebb600
https://doi.org/10.1016/j.cardfail.2020.09.080
https://doi.org/10.1016/j.cardfail.2020.09.080
Autor:
Abdur Rahman Khan, Sajjad Raza, Bashaer Gheyath, Faraz Khan Luni, Haitham M. Ahmed, Karim Abdur Rehman, Shehab AlAnsari, Haris Riaz, Richard A. Krasuski, Amr F. Barakat, Muhammad Shahzeb Khan
Publikováno v:
The American journal of cardiology. 120(5)
The prevalence of intolerance varies widely. Stopping statin therapy is associated with worse outcomes in patients with cardiovascular disease. Despite extensive studies, the benefits and risks of statins continue to be debated by clinicians and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3448b81f6b36eca4b50ad416bfff6064
https://pubmed.ncbi.nlm.nih.gov/28779871
https://pubmed.ncbi.nlm.nih.gov/28779871
Autor:
Stephanie Mick, Bassman Tappuni, Gillinov A. Marc, Rakesh M. Suri, Shehab AlAnsari, Marijan Koprivanac, Hoda Javadikasgari, Marta Kelava, Tomislav Mihaljevic
Given the increasing age of the US population and the accompanying rise in cardiovascular disease, we expect to see an increasing number of patients affected by degenerative mitral valve disease in a more complex patient population. Therefore, increa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d705b84f108d6fece75a302e118f346
https://europepmc.org/articles/PMC5293633/
https://europepmc.org/articles/PMC5293633/
Autor:
Allen G. Borowski, W.H. Wilson Tang, Vikram Sharma, Shehab AlAnsari, Brian D. Southern, Haris Riaz
Publikováno v:
Journal of Cardiac Failure. 25:S27
Background Pirfenidone, an FDA-approved novel anti-fibrotic agent used in the treatment of idiopathic pulmonary fibrosis (IPF), has been implicated in mitigating myocardial fibrosis, systolic and diastolic dysfunction in animal models (Kuwahara et al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f22dc5954599d2491bbf182eb8831cd
https://doi.org/10.1016/j.cardfail.2019.07.074
https://doi.org/10.1016/j.cardfail.2019.07.074